BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 8316308)

  • 1. [The treatment of obsessive-compulsory disorders (compulsory neuroses)].
    Hoogduin CA; Schaap CP
    Ned Tijdschr Geneeskd; 1993 Jun; 137(23):1135-8. PubMed ID: 8316308
    [No Abstract]   [Full Text] [Related]  

  • 2. Obsessive compulsive disorder.
    Soomro GM
    Clin Evid; 2003 Dec; (10):1172-87. PubMed ID: 15555141
    [No Abstract]   [Full Text] [Related]  

  • 3. Obsessive compulsive disorder.
    Soomro GM
    Clin Evid; 2004 Jun; (11):1319-34. PubMed ID: 15652061
    [No Abstract]   [Full Text] [Related]  

  • 4. Obsessive compulsive disorder.
    Soomro GM
    Clin Evid; 2005 Dec; (14):1270-83. PubMed ID: 16620454
    [No Abstract]   [Full Text] [Related]  

  • 5. Augmenting obsessive-compulsive disorder treatment: from brain to mind.
    Ressler KJ; Rothbaum BO
    JAMA Psychiatry; 2013 Nov; 70(11):1129-31. PubMed ID: 24026506
    [No Abstract]   [Full Text] [Related]  

  • 6. Obsessive-compulsive disorder.
    Veale D; Roberts A
    BMJ; 2014 Apr; 348():g2183. PubMed ID: 24709802
    [No Abstract]   [Full Text] [Related]  

  • 7. Cognitive-behavioral group therapy versus sertraline for obsessive-compulsive disorder: five-year follow-up.
    Borges CP; Meyer E; Ferrão YA; Souza FP; Sousa MB; Cordioli AV
    Psychother Psychosom; 2011; 80(4):249-50. PubMed ID: 21540627
    [No Abstract]   [Full Text] [Related]  

  • 8. When Improving Symptoms Is Not Enough-Is It Time for Next-Generation Interventions for Obsessive-Compulsive Disorder?
    Mataix-Cols D; Fernández de la Cruz L; Rück C
    JAMA Psychiatry; 2020 Jan; 77(1):9-10. PubMed ID: 31509171
    [No Abstract]   [Full Text] [Related]  

  • 9. Augmenting SRIs for Obsessive-Compulsive Disorder: Patient Preference for Risperidone Does Not Limit Effectiveness of Exposure and Ritual Prevention.
    Wheaton MG; Carpenter JK; Kalanthroff E; Foa EB; Simpson HB
    Psychother Psychosom; 2016; 85(5):314-6. PubMed ID: 27513584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive behavior therapy for pediatric obsessive-compulsive disorder.
    Wang Y
    JAMA; 2012 Feb; 307(6):560; author reply 560-1. PubMed ID: 22318271
    [No Abstract]   [Full Text] [Related]  

  • 11. Comorbid tics have no effect on response to cognitive-behavioral therapy in youth with obsessive-compulsive disorder.
    Hanna GL
    Evid Based Ment Health; 2015 Aug; 18(3):85. PubMed ID: 26126872
    [No Abstract]   [Full Text] [Related]  

  • 12. Augmentation with cognitive behavioural therapy has superior efficacy to augmentation with risperidone for treating adults with treatment-resistant OCD.
    O'Neill J
    Evid Based Ment Health; 2014 May; 17(2):58-9. PubMed ID: 24713316
    [No Abstract]   [Full Text] [Related]  

  • 13. Behavior therapy and serotonin dysregulation.
    Taylor S
    J Clin Psychiatry; 1997 Jul; 58(7):323-4. PubMed ID: 9269255
    [No Abstract]   [Full Text] [Related]  

  • 14. Behavioral therapy and serotonin reuptake inhibitor pharmacotherapy in the treatment of obsessive-compulsive disorder: a systematic review and meta-analysis of head-to-head randomized controlled trials.
    Romanelli RJ; Wu FM; Gamba R; Mojtabai R; Segal JB
    Depress Anxiety; 2014 Aug; 31(8):641-52. PubMed ID: 24390912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of cognitive-behavioral therapy addition to pharmacotherapy in resistant obsessive-compulsive disorder: a multicenter study.
    Albert U; Aguglia A; Bogetto F; Cieri L; Daniele M; Maina G; Necci R; Parena A; Salvati L; Tundo A
    Psychother Psychosom; 2012; 81(6):383-5. PubMed ID: 22964775
    [No Abstract]   [Full Text] [Related]  

  • 16. Special issue: Update on the nature and treatment of obsessive-compulsive-related disorders.
    Stanley M; Björgvinsson T; Frueh BC
    Bull Menninger Clin; 2010; 74(2):iii-vi. PubMed ID: 20545490
    [No Abstract]   [Full Text] [Related]  

  • 17. Outcome of additional behaviour therapy including treatment discontinuation for fluvoxamine non-responders with obsessive-compulsive disorder.
    Nakatani E; Nakagawa A
    Psychother Psychosom; 2008; 77(6):393-4. PubMed ID: 18716426
    [No Abstract]   [Full Text] [Related]  

  • 18. Obsessive-compulsive disorder: strategies for using CBT and pharmacotherapy.
    Storch EA; Merlo LJ
    J Fam Pract; 2006 Apr; 55(4):329-33. PubMed ID: 16608672
    [No Abstract]   [Full Text] [Related]  

  • 19. Treating obsessive-compulsive disorder. Options include medication, psychotherapy, surgery, and deep brain stimulation.
    Harv Ment Health Lett; 2009 Mar; 25(9):4-5. PubMed ID: 19368037
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cognitive-behavior therapy for obsessive-compulsive disorder: a systematic review of the last decade].
    Prazeres AM; Souza WF; Fontenelle LF
    Braz J Psychiatry; 2007 Sep; 29(3):262-70. PubMed ID: 17713699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.